Xplocid-SR Capsule
Images are for reference. Actual packaging may vary.
Domperidone (30mg) + Rabeprazole (20mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Domperidone antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, inhibiting nausea and vomiting.
Rabeprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Medical applications
Xplocid-SR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Rabeprazole 20 mg, designed for the management of gastrointestinal disorders associated with acid reflux and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the tone of the lower esophageal sphincter and accelerating gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating.
Rabeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release formulation of Xplocid-SR ensures prolonged therapeutic plasma concentrations, optimizing symptom control and improving patient compliance.
This combination is particularly beneficial in patients requiring both acid suppression and prokinetic effects to manage complex upper gastrointestinal symptoms. Xplocid-SR should be administered under medical supervision, considering contraindications such as known hypersensitivity to its components and caution in patients with cardiac arrhythmias or hepatic impairment. Regular monitoring is advised to assess therapeutic efficacy and detect potential adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Xplocid-SR Capsule







